From Fighting Shoplifting to Pioneering Gene Therapies, the Startups in This Accelerator Are on the Front Lines of “Super Creativity”
The startups within UF Innovate, as well as the accelerator itself, are vivid examples of what creativity and innovation expert James Taylor, based in Scotland, describes as SuperCreativity—a phenomenon that many business leaders are trying to foster in today’s fast-changing business environment. It is a concept that goes beyond creativity or innovation alone.
Arranta Bio Named Honoree in GrowFL Companies to Watch
Arranta Bio is pleased to be among the top 50 second-stage companies in Florida selected as honorees in the 2020 GrowFL Florida Companies to Watch, a statewide competition that identifies companies expected to see significant growth over the next several years. The 2020 GrowFL Florida Companies to Watch awards celebration is brought to you by […]
Selecting a Microbiome CDMO Partner for the Long Term, Arranta Bio Shares
As more microbiome-based therapies progress through the clinic toward approval for market launch, concerns over the lack of outsourcing capacity for process development and commercial manufacturing of live biotherapeutic products are increasing. Arranta Bio is investing heavily in both its process development and cGMP manufacturing capabilities for the supply of clinical trial material and in […]
Arranta Bio Announces Completion of Its Microbiome Process Development Laboratory Expansion and Commitment to Additional Early Clinical GMP Capacity
Arranta Bio, the leading microbiome contract development and manufacturing organization (CDMO), announced the completion of its process development laboratory expansion project and a commitment to add additional early-clinical GMP capacity at its Center of Excellence for Microbiome Process Development and Early Clinical Supply. Arranta has completed the expansion of purpose-built microbiome process development laboratories in […]
Reflections on a 10-Year Journey in the Microbiome
Following a fortuitous path, researcher Aaron Cowley established expertise in process development for live biotherapeutic products at his company Captozyme. Today, as part of CDMO Arranta Bio, he is looking forward to helping drug developers bring the first microbiome-based therapies to the market. Dr. Aaron B. Cowley is the chief scientific officer at Arranta Bio, […]
Arranta Bio Announces Key Leadership Additions As It Commits to a $100M Investment in Building End-to-End Microbiome Capacity
Arranta Bio, the leading microbiome contract development and manufacturing organization (CDMO), announced the strengthening of its senior leadership team with the addition of David Stevens as Chief Operations Officer and Jason Rahal as Senior Vice President of Business Development. Arranta has committed $100M to build end-to-end capacity as the first dedicated microbiome CDMO. Arranta Bio […]